CAS: 82475-03-4

Baicalin methyl ester is a methylated flavonoid derivative, which is a modified form of the flavonoid compound baicalin. It is sourced from Scutellaria baicalensis, a medicinal herb traditionally used in Chinese medicine. The methylation process enhances the bioavailability and stability of the compound compared to its parent molecule. The mode of action of baicalin methyl ester involves the inhibition of pro-inflammatory pathways and modulation of oxidative stress mechanisms. It effectively disrupts the NF-κB pathway, which plays a crucial role in the inflammatory response. Additionally, it exhibits antioxidant properties that mitigate cellular oxidative damage. Baicalin methyl ester finds applications in research focused on inflammatory diseases, including arthritis and neuroinflammatory conditions. Due to its enhanced properties, it is of particular interest in pharmaceutical development as a lead compound for anti-inflammatory drugs. Current studies explore its potential in targeting specific inflammatory pathways, offering insights into novel therapeutic strategies for managing chronic inflammatory conditions.

Baicalin methyl ester shows inhibitory effects on the Avian Myeloblastosis Virus reverse transcriptase (AMV-RT).

Baicalin methyl ester shows inhibitory effects on the Avian Myeloblastosis Virus reverse transcriptase (AMV-RT).

Baicalin methyl ester